Makena Follows Avastin’s Path With US FDA Hearing On Accelerated Approval Withdrawal

Footsteps in sand
Covis is following Genentech's footsteps on a route that will take the Makena sponsor to a public hearing under the accelerated approval regulations. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Review Pathways

More from Pathways & Standards